Related by context. All words. (Click for frequent words.) 74 SYCREST 73 Initiates Enrollment 71 Receives Approvable Letter 71 Submits NDA 71 Granted Orphan Drug 71 INTEGRILIN R eptifibatide Injection 71 rasagiline tablets 70 Receives Orphan Drug 70 Frozen Shoulder syndrome 70 Initiates Clinical 70 Receives Orphan Drug Designation 70 MOVIPREP R 69 Preotact R 69 Somatuline Depot 69 Amitiza ® 69 Files IND 69 BioSante Pharmaceuticals Announces 68 Submits Biologics License Application 68 Initiates Phase III 68 Receive Milestone Payment 68 Psoriasis Drug 68 methylnaltrexone bromide 68 VIVITROL ® 68 Cloderm ® Cream 68 Receives CE Marking 68 Raptiva R 68 Receives Positive Opinion 68 Completes Patient Enrollment 68 ZEVALIN ® 68 Demonstrates Significant 68 NeoVisc ® 68 Somatuline R Depot 68 BioElectronics Announces 68 Somatuline R Autogel R 68 Announces Tentative Approval 68 Initiates Clinical Trial 68 Dermylex TM 67 RECOTHROM ® 67 Initiates Phase II 67 Initiates Clinical Trials 67 Interferon Alpha 67 Kuvan R 67 Receives Milestone Payment 67 Orapred ODT 67 Phase III Clinical Trial 67 Submits Response 67 AMITIZA ® 67 RECOTHROM R 67 Rheumatoid Arthritis Drug 67 Aphthasol R 67 ® bortezomib 67 COLAZAL R 67 FDA Accepts 67 markets HP Acthar 67 FACTIVE ® 66 Prolongs Survival 66 NUEDEXTA ™ 66 XIAPEX 66 Receives Tentative FDA 66 XIAPEX ® 66 oral salmon calcitonin 66 GTC recombinant form 66 Intravenous Human 66 Begins Dosing 66 Tibotec BVBA 66 THALOMID 66 Enters Into Collaboration 66 Investigational Treatment 66 Misonix Announces 66 Hsp# Inhibitor 66 Glatiramer Acetate 66 Aloxi ® 66 FDA APPROVES 66 STELARA TM 66 CONBRIZA 66 ZALBIN 66 XIAFLEX ® 66 Prostate Cancer Vaccine 66 Initiate Clinical Trial 66 Meets Primary Endpoint 66 Crofelemer budesonide foam 66 Therapeutic Competitors Companies 66 Receives Marketing Authorization 66 Teva Provides Update 66 Increlex R 66 FDA Approvals 66 BEMA Fentanyl 66 Single Dose 66 Methylphenidate Transdermal System 66 CARBATROL 66 Aloxi R 66 JAK2 Inhibitor 66 ABILIFY ® 66 Vitrasert R 66 Modrenal R 66 acyclovir Lauriad R 66 POSIDUR TM 66 LEVADEX ™ 66 Patient Enrollment 65 Receives Fast Track 65 Xenazine ® 65 Announces Poster Presentations 65 Xian Janssen 65 Preotact 65 Receives Tentative Approval 65 AMITIZA R 65 Thelin tm 65 FOR FURTHER INFORMATION ABOUT 65 Mimpara R 65 Expanded Indication 65 SPRYCEL ® 65 Drug Candidate 65 Zorbtive TM 65 HuMax TAC 65 Wafer polifeprosan 65 Zegerid OTC 65 Combination REOLYSIN R 65 BEMA Granisetron 65 Azithromycin Dispersible Tablets 65 Sumatriptan Succinate 65 OMNARIS HFA 65 Presents Positive 65 Announce Collaboration Agreement 65 Submits Application 65 ABILIFY R 65 Benicar HCT 65 successfully commercialize Iluvien 65 Pirfenidone 65 Therapeutic Vaccine 65 RELISTOR methylnaltrexone bromide 65 Generic Versions 65 Demonstrates Sustained 65 Loramyc TM 65 Achieves Primary Endpoint 65 Fast Track Status 65 Investigational Compound 65 Fabry Disease 65 Submits IND 65 Mylan Receives Approval 65 OMNARIS Nasal Spray 65 Generic Version Of 65 HP Acthar R 65 Dermylex 65 label Lipofen R 65 Release Capsules 65 Pirespa 65 Tyzeka Sebivo 65 Present Preclinical Data 65 Xolegel 65 Presents Preclinical Data 65 Alvesco R 65 Gets FDA Clearance 65 Abstral ™ 65 THALOMID R 65 Completes Enrollment 65 liver resection surgeries 65 doxercalciferol 65 Xcytrin R 64 Nipent R 64 oncolytic virus therapies 64 Taiho Pharmaceutical 64 Significantly Improves 64 Keppra ® XR 64 Loramyc R 64 Receives SFDA Approval 64 Azilect R 64 Aztreonam Lysine 64 Demonstrates Positive 64 Morphine Sulfate 64 ARIXTRA R 64 BioGlue ® 64 Extends Collaboration 64 Fortical R 64 TRISENOX R arsenic trioxide 64 Demonstrates Statistically Significant 64 Commence Phase 64 Rotarix R 64 Release Tablets 64 Lovaza TM 64 Announce License Agreement 64 BioGlue R 64 ARCALYST R 64 Amlodipine Besylate 64 PRN FDA Approves 64 miconazole Lauriad ® 64 Personalized Immunotherapy 64 Initiates Dosing 64 R memantine HCl 64 Announce Licensing Agreement 64 Sebivo 64 BARACLUDE R 64 Levoleucovorin 64 syndrome overactive bladder 64 Alexion Soliris 64 Tracleer R 64 RHEI Pharmaceuticals 64 Pivotal Phase III 64 Carbidopa Levodopa 64 CIP TRAMADOL ER 64 Trobalt 64 Phase 2b Clinical Trial 64 YONDELIS 64 Presents Preclinical 64 Desvenlafaxine 64 Ceflatonin R 64 TRANSDUR ™ 64 DepoCyt 64 Kineret R 64 Begins Clinical Trial 64 Transcept Pharmaceuticals 64 ONSOLIS 64 Oracea ® 64 Flamel Technologies Announces 64 CAMPATH R 64 Angiox ® 64 Serdolect ® 64 Civacir 64 Omacor ® 64 Submits Investigational 64 Pafuramidine 64 Ganciclovir 64 Nycomed GmbH 64 Tezampanel 64 Alvesco ® 64 Drug Fails 64 Pivotal Study 64 OLEPTRO 64 Eligard R 64 Immunosuppressant 64 Oral Insulin 64 highly purified pasteurized 64 Thrombin topical Recombinant 64 Reports Preclinical Data 64 R bivalirudin 64 Phase 2a Trial 64 Recombinant Human 64 Peyronie disease Frozen Shoulder 64 DP VPA 64 Lupus Drug 64 NDA Submission 64 Generic Version 64 Transdermal Patch 64 Marketing Authorisation Application 64 Gentamicin Surgical Implant 64 Renal Cancer 64 LEVADEX TM 64 Sycrest 64 oritavancin semi 64 arsenic trioxide injection 64 SPL# Gel vaginal microbicide 64 PLAVIX ® 64 #mg Tablets [002] 64 Peginterferon alfa 2b 64 SAFLUTAN 64 ATRIPLA TM 64 Immunotherapeutic 64 Seasonal Influenza Vaccine 64 Fanapt ® 64 Phase IIa Clinical Trial 64 Therapeutic Competitors Report 64 Xyrem ® 64 Bazedoxifene 64 Kuvan TM sapropterin 64 VANTAS 64 Indomethacin 64 ZANAFLEX CAPSULES ® tizanidine 63 cosmetic cosmeceutical products 63 Glycopyrrolate 63 LUCASSIN 63 mesylate tablets approved 63 rhFVIIa 63 Nivestim 63 Aceon 63 Sanvar R 63 FDA Okays 63 ORENCIA R 63 Antitumor 63 Salix Pharmaceuticals Announces 63 Files Investigational 63 BioElectronics Corporation Announces 63 Successfully Completes Phase 63 Tibotec Pharmaceuticals Ltd. 63 Application MAA 63 miconazole MBT 63 Nanophase Announces 63 Betaferon R 63 Abstral ® 63 Qutenza TM 63 Protease Inhibitor 63 BUPHENYL R 63 Announces FDA Clearance 63 RAPTIVA 63 Febuxostat 63 Onko Sure TM 63 Pegloticase 63 Testim R 63 Monovisc 63 Adjuvant Treatment 63 Twinject R 63 Campto 63 Ondansetron Injection 63 HCV Protease Inhibitor 63 Tostrex 63 Kosan dependence 63 Ranexa R 63 HCl Tablets 63 Aryplase 63 STRIANT ® 63 CAMPATH 63 palonosetron hydrochloride injection 63 Emezine 63 Milnacipran 63 R pegaptanib sodium 63 UPLYSO 63 Orphan Status 63 Kristalose ® lactulose 63 FACTIVE R gemifloxacin 63 Zenpep 63 Octreotide 63 SUMAVEL 63 Clolar ® 63 Alferon N 63 proprietary intravenous formulation 63 FUZEON ® 63 RAPTIVA r 63 Eligard ® 63 Zeneus 63 Renvela ® 63 Romiplostim 63 ESTRASORB ® 63 Phase IIb Clinical Trial 63 Submits Supplemental 63 JAK Inhibitor 63 Phase III Trials 63 TRISENOX R 63 Besivance 63 Evoltra ® 63 SinuNase ™ 63 NeoVisc R 63 Silodosin 63 Galantamine 63 Abstract Accepted 63 Alferon N Injection 63 personalized cellular immunotherapy 63 Rectogesic 63 ACOMPLIA R 63 Saforis 63 Arzerra TM 63 VYVANSE TM lisdexamfetamine 63 Tetrabenazine 63 REBETOL combination 63 memantine HCl 63 Milestone Payment 63 Influenza Vaccine 63 Zavesca r 63 Data Suggest 63 Presents Positive Preclinical 63 SUPPRELIN LA 63 Cleviprex TM clevidipine 63 glucokinase activator 63 FOLOTYN ® 63 Marqibo TM 63 Unigene nasal calcitonin 63 Toremifene 63 R bendamustine hydrochloride 63 FDA Clears 63 Begins Shipment 63 XAGRID 63 histamine dihydrochloride 63 Clinical Trial Results 63 novel histone deacetylase 63 Pennsaid topical non steroidal 63 Taro Receives 63 Announces Rebranding 63 PROVENGE ® 63 gets USFDA nod 63 Aridol TM 63 Aloprim TM allopurinol sodium 63 STRIANT 63 Initiate Phase III 63 hydrochloride tablets 63 ADDERALL XR R 63 Solagé ® mequinol 63 Sodium Injection 63 INTERNATIONAL HOLDINGS INC. 63 Vidaza R 63 XIAFLEX TM 63 BioNumerik 63 vancomycin hydrochloride 63 PROCHIEVE ® 63 Mycophenolate Mofetil 63 vinorelbine tartrate 63 Phase IIb Trial 63 Fludara ® 63 PHX# 63 levocetirizine 63 Neulasta R 63 Nicotine Vaccine 63 Irinotecan Hydrochloride Injection 63 ESTRASORB R 63 Argatroban 63 Orphan Drug designations 63 Psivida 63 Cellegesic 63 Silenor ® 63 equine osteoarthritis marketed 63 Nabi HB R 63 Begin Clinical Trials 63 orally disintegrating formulation 63 Raptiva ® 63 Advanced Melanoma 63 ® lenalidomide 63 Increlex TM 63 topical ophthalmic 63 Shows Promise Against 63 Tesamorelin 63 Heska Announces 63 Thalidomide Pharmion 63 ACEON R perindopril erbumine 63 GATTEX TM 63 LibiGel ® 63 TRANSDUR Bupivacaine 63 FDA Approvable Letter 62 Atelvia 62 Zirgan 62 epoprostenol sodium 62 STERIS Corporation Announces 62 Gleevec Glivec 62 Phase III Trial 62 Vitrasert ® 62 Loramyc ™ 62 Vivecon 62 ZADAXIN ® 62 Launches Generic Version 62 Cumulase 62 Oxytrol R 62 TYZEKA 62 ACAPODENE R 62 platform HDL Mimetic 62 Meritage Pharma 62 Eloxatin ® 62 Ralivia TM 62 Kyowa Kirin 62 Testosterone Gel 62 Licenses Novel 62 Combunox 62 Resubmission 62 Beyond Advair 62 TB Vaccine 62 Surfaxin LS 62 include Alferon N 62 Savella ® 62 Grants Orphan Drug 62 RYZOLT 62 sublingual tablets 62 Embosphere R 62 vapreotide acetate 62 Orphan Drugs 62 balsalazide disodium Capsules 62 GeneraMedix 62 HepaGam B R 62 Phase 2b Trial 62 Tracleer r 62 PF # [002] 62 VIVUS Announces 62 Uracyst 62 Aeolus Pharmaceuticals Announces 62 Demonstrates Potential 62 Panzem R 62 Gel repository corticotropin injection 62 BRILINTA 62 RISPERDAL ® CONSTA ® 62 HFA MDI 62 Cethrin R 62 Vicriviroc 62 azilsartan medoxomil 62 Elagolix 62 nasal calcitonin product 62 Xyzal ® 62 Cypher Sirolimus 62 TRANSDUR ® 62 Ixempra 62 ONCASPAR 62 Bertek Pharmaceuticals 62 Japanese Encephalitis Vaccine 62 Lubiprostone 62 Proquin XR 62 nalbuphine ER 62 RANK Ligand inhibitor 62 PREVU * POC 62 IPSEN 62 Auxilium Pharma 62 Kissei Pharmaceutical 62 Obtains Approval 62 ferumoxytol Injection 62 Evoltra 62 intravenous AAT 62 therapeutically inactive prodrug 62 Certican 62 GTC recombinant human 62 hyaluronidase enzyme 62 Xeloda ® 62 treat chronic sinusitis 62 ZEFTERA TM 62 Obtains CE Mark 62 acetonide FA 62 palonosetron hydrochloride Injection Dacogen 62 CIMZIA r 62 Telik Announces 62 Tegaserod 62 R bortezomib 62 Schizophrenia Treatment 62 VISICOL R 62 Visudyne R 62 SUPPRELIN R LA 62 Dermylex R 62 Phase 2a Clinical Trial 62 SUTENT ® 62 Adenuric R 62 Sylvie Gregoire President 62 Alpha interferons including 62 initiated Phase Ib 62 GLASSIA 62 Captisol enabled 62 ZEFTERA TM Zevtera TM 62 Recommends Approval 62 Cellegesic TM nitroglycerin ointment 62 5 lipoxygenase inhibitor 62 Strengthens Balance Sheet 62 Prodarsan R 62 Lysteda 62 Perindopril 62 cMET inhibitor 62 Soriatane 62 Bacterin develops manufactures 62 Soliris eculizumab 62 estradiol transdermal spray 62 TAXUS Element Stent System 62 Tigecycline 62 ORADUR ® 62 JV SpeBio 62 Preotact ® 62 Loramyc 62 Omigard TM 62 Gout Drug 62 Handok Pharmaceuticals 62 Extended Release Tablets 62 Anticancer Drug 62 Campath ® 62 Synvisc ONE 62 Marketing Authorization Applications 62 Xibrom TM 62 Gonal f 62 Calcium Acetate 62 Oral Solution 62 Fondaparinux 62 Amends Agreement 62 subsidiaries visit http:/www.apricusbio.com 62 Sign Licensing Agreement 62 Inhaled Insulin 62 sitaxsentan sodium 62 VANTAS ® 62 Develop Novel 62 albiglutide 62 Asmanex 62 Commercialize Novel 62 Patients Treated With 62 IMiDs ® 62 Maribavir 62 Vitaros ® 62 Rotavirus Vaccine 62 Levocetirizine 62 Fosphenytoin 62 ™ pralatrexate injection 62 IV Busulfex 62 Receives Clearance 62 IND Application 62 synthetic peptide containing 62 Oral Calcitonin 62 TEMODAL 62 Stavzor 62 Agenerase 62 FUSILEV ® 62 Pazopanib 62 Tramiprosate ALZHEMED TM 62 intranasal formulation 62 GVAX ® 62 Synerx Pharma 62 fexofenadine hydrochloride 62 Twinject ® 61 R sorafenib tablets 61 Vimpat ® lacosamide 61 Abelcet 61 Medicure Announces 61 Acute Heart Failure 61 Supplemental Biologics License Application 61 DepoDur 61 Phase III Pivotal 61 Vitaflo Scandinavia AB 61 ARRY # 61 Saquinavir 61 STRIANT R 61 fluoroquinolone antibiotic 61 Myocet 61 Patient Enrolment 61 Milestone Payments 61 Receives Complete Response 61 Extended Release Capsules 61 Nitoman 61 Anticancer Agent 61 PENTASA 61 Solstice Neurosciences 61 Clinical Trial Data 61 Finacea 61 Commences Phase 61 BENLYSTA ® 61 dextromethorphan quinidine 61 ENLIGHT 61 Pruvel TM 61 Taisho Pharmaceuticals 61 Terbinafine 61 Significantly Improved 61 Glufast 61 Vitaros R 61 Commences Phase III 61 duloxetine hydrochloride 61 Inc Therapeutic Competitors 61 registrational studies 61 Sular ® 61 Eraxis 61 Chronic Hepatitis B 61 Dantrium R 61 Cetrorelix 61 vaccine Synflorix 61 evaluating picoplatin 61 Bupropion HCl ER 61 NerPharMa 61 Initiates Phase 2b 61 RNAi Therapeutic 61 Etanercept 61 Embosphere Microspheres 61 Dual Opioid 61 Reveals Positive 61 Interferon beta 1a 61 telomerase therapeutic 61 Completes Dosing 61 Secures Financing 61 oral prodrug 61 Epilepsy Drug 61 sNDAs 61 Cefprozil 61 RELOVAIR ™ 61 Multaq dronedarone 61 Severe Sepsis 61 Tracleer ® bosentan 61 ITAX 61 Confirms Efficacy 61 Trastuzumab DM1 61 Pennsaid ® 61 Voluntarily Withdraws 61 Initiate Phase 61 Invicorp R 61 Anidulafungin 61 Xyntha 61 delivery polymer matrix 61 PREOS R 61 product Fentanyl TAIFUN 61 ciprofloxacin hydrochloride 61 Lung Cancer Drug 61 HP Acthar r 61 Frova ® 61 Solasia 61 Loramyc ® 61 QVAR 61 Atypical Hemolytic Uremic Syndrome 61 Fluconazole 61 Sensipar R 61 developing Zerenex ferric 61 SABER ™ 61 include Altastaph TM 61 Valtropin 61 Cholesterol Lowering Drug 61 Positive Opinion 61 Solzira ™ 61 ELADUR ™ 61 lucinactant 61 Pivotal Clinical Trial 61 Indaflex TM 61 orphan designation 61 Zeldox 61 Oxcarbazepine 61 dutogliptin 61 Pivotal Trial 61 Granulocyte Colony Stimulating Factor 61 NitroMist TM 61 RAZADYNE 61 Eszopiclone 61 Fanapt TM 61 REBETOL combination therapy 61 cyclobenzaprine hydrochloride extended 61 CYCLOSET ® 61 Gamunex C 61 Aldara ® 61 methylphenidate transdermal system 61 Clinical Study Shows 61 Polyphenon ® E 61 Verus Pharmaceuticals 61 Ozarelix 61 EnzymeRx 61 Files Patent Application 61 Boniva ibandronate 61 commercialize AzaSite 61 IV APAP 61 Fenoglide 61 buccal spray 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 Plenaxis R 61 Ceragenin ™ 61 Liprotamase 61 Nexavar ® 61 Wound Dressing 61 Vaccine Adjuvants 61 Diamyd Medical Diamyd 61 LUNESTA ® 61 Enrolls First 61 Naprelan R 61 DepoDur TM 61 Perforomist ™ Inhalation Solution 61 PrandiMet 61 Kepivance 61 Glufosfamide 61 Strengthens Position 61 novel emulsion formulation 61 ZEGERID Capsules 61 EpiCeram 61 Inhalation Solution 61 Exploit collaboration 61 Arixtra ® 61 Receives Approvals 61 Doripenem 61 Ixabepilone 61 Earns Milestone Payment 61 Nexavar sorafenib tablets 61 ELADUR TM 61 ZFP Therapeutics 61 Potelligent Technology 61 Iloperidone 61 Myrexis Inc. 61 Generic Lovenox 61 DosePro TM 61 fentanyl citrate C 61 Teikoku Pharma USA 61 plasma protein biotherapeutics 61 NICE Recommends 61 AzaSite TM 61 Announces Licensing Agreement 61 Receives Conditional 61 Zanaflex Capsules ® tizanidine 61 Stereotaxis Announces 61 XIENCE V Stent System 61 Nabi HB Intravenous 61 Ciclesonide 61 Migraine Drug 61 BYETTA ® 61 fluvoxamine maleate 61 Bayer Onyx 61 ACTONEL 61 apomorphine hydrochloride 61 hyperimmune products 61 Oxaliplatin 61 FDA Approves Generic 61 outlicensed 61 testosterone buccal system 61 Archexin 61 Metformin HCl 61 Inhalation Aerosol 61 BioSante Pharmaceuticals Reports 61 ONTAK 61 Stanate R 61 STO SOBI 61 Elan Pharma 61 Staphylococcus aureus Immune Globulin 61 First Patient Dosed 61 INSPIRE Trial Phase III 61 DepoBupivacaine TM 61 Prism Pharmaceuticals 61 silodosin 61 candidates Azedra TM 61 DIFICID ™ 61 Dynepo TM 61 Zidovudine Tablets 61 Injection Site 61 Lispro 61 Tibotec Therapeutics division 61 HYVISC R 61 Calcitonin 61 BrachySil TM 61 Obtains License 61 Aricept donepezil 61 Sanctura XR 61 Risperidone Oral Solution 61 BiovaxID TM 61 nonsedating antihistamine 61 BiDil XR 61 GSK '# 61 single injection viscosupplement 61 Chipscreen 61 inhaled treprostinil 61 AFREZZA TM 61 Striant R 61 Vernalis plc 61 Announces Consummation 61 Surgical Adhesive 61 Nascobal R 61 XOPENEX R 61 Anti Tumor 61 Bosutinib 61 Systemic Delivery 61 5 HT3 antagonist 61 AcryMed Incorporated 61 Antibody Drug Conjugate 61 Oral Suspension USP 61 Oxaliplatin Injection 61 candidate TNFerade biologic 61 thetreatment 61 Zenvia ™ 61 Vaccine Adjuvant 61 IMiDs ® compound 61 SOLTAMOX TM tamoxifen citrate 61 Anti Inflammatory 61 Pandemic Influenza Vaccines 61 Posaconazole 60 Emollient Foam 60 Announce Merger Agreement 60 ularitide 60 Retacrit 60 Lixisenatide 60 Drug Formulation 60 Pandemic Flu Vaccine 60 MEZAVANT 60 XYOTAX TM 60 PROTONIX 60 ® fenofibrate capsules 60 Potent Antiviral Activity 60 Syncria R 60 Frozen Shoulder Syndrome 60 beta 1a 60 FDA Panel Recommends 60 CyDex Pharmaceuticals 60 Fortigel 60 ONGLYZA ™ 60 Abacavir Sulfate 60 TRISENOX 60 NeoVisc 60 Reacquires 60 HepaSphere 60 balsalazide tablet 60 topical non steroidal 60 OMNARIS 60 hepatitis B immune globulin 60 injectable formulations 60 TSX PLB 60 Focalin XR ® 60 Neupogen ® 60 Bendamustine 60 Amlodipine Besylate Tablets 60 topical NSAID 60 Phase 2a Study 60 sumatriptan injection 60 Benazepril 60 RHEI 60 Taclonex Scalp R 60 Develops Novel 60 Efficacy Trial 60 TheraSphere R 60 Urokinase 60 Nippon Shinyaku 60 Actimmune ® 60 Genpharm 60 subsidiary Glenmark Generics 60 Catena ® 60 AnGes MG Inc. 60 Naglazyme 60 Pulmonary Arterial Hypertension 60 REPRONEX R menotropins 60 Zemiva TM 60 Glucophage R 60 Anti Infective 60 Hematological Malignancies 60 Rotarix ® 60 MERREM IV 60 Maleate 60 Melphalan 60 AVI BioPharma Announces 60 Harry Palmin President 60 compound KOS 60 ADAGEN 60 AMITIZA lubiprostone 60 First Patient Enrolled 60 BEMA ® 60 Validus Pharmaceuticals 60 XOPENEX Inhalation Solution 60 cinacalcet HCl 60 Improves Outcomes 60 antiretroviral medicinal 60 Vascugel 60 Celgene Thalomid 60 sapropterin dihydrochloride Tablets 60 nilotinib Tasigna 60 Improves Survival 60 Guidelines Issued 60 novel trazodone formulation 60 Tramadol ER 60 Sumatriptan 60 Study Showed 60 rxRNA 60 Regeneron Pharma 60 PDUFA Date 60 Drug Submission 60 TM Drug Eluting 60 Deferiprone 60 REG1 Anticoagulation System 60 Adjunctive Therapy 60 GVAX R 60 Demonstrates Potent 60 inhaled AAT 60 LUCENTIS r 60 Xyzal R 60 HCV RNA polymerase 60 FDA Approves 60 Esmya 60 Tiuxetan 60 JOULFERON 60 DURIN TM 60 FDA Orphan Drug 60 Icatibant 60 Fixed Dose Combination 60 formerly LymphoStat B 60 REMINYL ® 60 Shows Statistically Significant 60 refractory chronic lymphocytic 60 orally disintegrating 60 Receives Approval From 60 Oasmia 60 Receives Regulatory 60 Stavzor TM 60 Azilect ® 60 pralatrexate injection folate analogue 60 Sinobiopharma 60 Zanaflex Capsules TM 60 Insegia 60 #L Sterilizer 60 Friedreich Ataxia FRDA 60 IMiDs R 60 SNT MC# 60 Immunomedics Announces 60 novel orally inhaled 60 miconazole Lauriad R 60 Shows Promising 60 Gonal f ® 60 olmesartan medoxomil hydrochlorothiazide 60 Oral Formulation 60 STEDESA 60 Dalbavancin 60 Circ Pharma 60 antibiotic amikacin 60 INTEGRILIN ® 60 MKC# MKC# PP 60 Successfully Concludes 60 LymphoStat B TM 60 Schizophrenia Drug 60 POSIDUR TM ELADUR TM 60 VNS Therapy TM 60 IMiDs 60 MAA submission 60 Allovectin 7 r 60 Omnaris 60 soft gelatin capsule 60 CLARINEX 60 Allegra Oral Suspension 60 products Oncaspar ® 60 Vivelle Dot ® 60 Noxafil 60 Dexilant 60 Paliperidone Palmitate 60 Ondansetron Orally Disintegrating Tablets 60 sapropterin dihydrochloride 60 Coria Laboratories 60 Ethyol 60 Aviptadil 60 RhuDex 60 R lenalidomide 60 Akorn Strides 60 NEBIDO VANTAS SUPPRELIN LA 60 Divalproex Sodium 60 CDP# 60 OTC ZEGERID 60 Berinert 60 REMICADE infliximab